Recombinant Mouse Defb33 Protein ，His & SUMO

Defb33 is a member of the β-defensin family, which plays a crucial role in the innate immune response. These small cationic peptides are primarily produced by epithelial cells and exhibit antimicrobial activities against a broad spectrum of pathogens, including bacteria, fungi, and viruses. The study of Defb33 has gained importance due to its potential implications in immunology and therapeutic applications. Recent research has suggested that Defb33 not only functions as an antimicrobial agent but also plays a role in modulating the immune response by influencing inflammation and wound healing processes. The understanding of its structure-function relationship has been enhanced through recombinant protein technology, enabling the production of Defb33 in various systems for detailed functional assays. This research has broader implications, particularly in understanding host defense mechanisms and developing novel antimicrobial peptides that could serve as alternatives to conventional antibiotics. Furthermore, alterations in the expression levels of β-defensins, including Defb33, have been linked to various diseases, making it a target of interest in medical research. With the increasing prevalence of antibiotic resistance, the exploration of Defb33 and similar peptides could yield valuable insights and strategies for combating infections and enhancing human health.